An Edmond, Oklahoma doctor has been fined $110,000 after allegations that he violated the Comprehensive Drug Abuse Prevention and Control Act of 1970. The U.S. Attorney’s office announced that Dr. Edward Shadid, a spinal surgeon, was penalized for mishandling controlled substances at his clinics.
Details of the Violation
Dr. Shadid, who operates Spine and Pain Edmond and Spine and Pain Lawton, was found to have committed several infractions related to the handling and transfer of controlled substances. Specifically, he failed to:
- Use proper DEA forms when transferring controlled substances between the Edmond and Lawton locations.
- Obtain a separate DEA registration for the Lawton clinic, which is required to legally handle and dispense controlled substances.
- Maintain a proper inventory of controlled substances stored at both clinics.
These failures led to the civil penalties, as the U.S. Attorney’s office emphasized the importance of compliance with drug control laws for ensuring patient safety and preventing misuse.
Dr. Shadid’s Response
In the settlement agreement, Dr. Edward Shadid did not admit liability for the violations. The fine of $110,000 was paid as part of a resolution to avoid further legal proceedings.
Implications of the Settlement
This settlement underscores the importance of adhering to federal regulations concerning controlled substances. The Comprehensive Drug Abuse Prevention and Control Act is designed to ensure that controlled substances are properly documented, registered, and inventoried to reduce the risk of abuse and illegal distribution.
The penalties imposed on Dr. Shadid serve as a reminder to medical professionals to maintain strict compliance with all regulatory requirements when handling sensitive medications.
Statement from Attorney Robert J. Troester’s Office:
Recordkeeping is a vital part of managing controlled substances. Complete and accurate records help avoid diversions and losses of controlled drugs. A Drug Enforcement Administration (“DEA”) registrant who transfers controlled substances between locations must comply with the applicable requirements as well as register with the DEA for each principal place of business or professional practice where controlled substances are stored. Registrants must also follow the inventory requirements when purchasing and storing controlled substances. Failure to do so subjects the registrant to civil monetary penalties.
